At the Cleveland Clinic, researchers are testing a preventive breast cancer vaccine, and results from Phase 1 of the trial are showing promising signs.

Platelet rich plasma may increase hair density in breast cancer survivors with endocrine- and chemotherapy-induced alopecia, ...

The optimal approach to treatment in the post-CDK4/6 inhibitor setting remains undefined, but multiple strategies have ...

In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...

Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...

Bang Bang” singer Jessie J, 37, has been center stage this year not just for her performances, but because she’s sharing her ...

BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, ...

The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...

Datopotamab deruxtecan received FDA approval for HR+/HER2– breast cancer, improving progression-free survival and overall ...

A large-scale study by Chinese researchers offers a new treatment path for patients with the most aggressive form of breast ...

This week Dr. Diana Bitner shares the story of a man she met who is living with breast cancer, and why the holiday season can ...

This gift marks the 17th year of the event, which raised over $72,000 during the Oct. 3 fundraiser and auction at Nashville ...